Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma

Clinical Cancer Research

Volumn 7, Issue 10, 2001, Pages 3113-3119

  Kallakury, Bhaskar V S ^a   Karikehalli, Shridevi ^a   Sheehan, Christine E ^a   Ross, Jeffrey S ^a   Haholu, Aptullah ^b   Azumi, Norio ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; PARAFFIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL TYPE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

CARCINOMA, RENAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0034798212     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Matrix metalloproteinases
2. Matrix metalloproteinases and their inhibitors
3. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinase 1 in patients with rheumatoid arthritis
4. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
5. Matrix metalloproteinase in tumour invasion and metastasis
6. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
7. Potential applications of tissue inhibitor of metalloproteinase (TIMP) overexpression for cancer gene therapy
8. Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer
9. Tissue levels of matrix metalloproteinase MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
10. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
11. Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma
12. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in human pancreatic carcinoma
13. Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression
14. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin (ogen) in lung neoplasms: An immunohistochemical study
15. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: Purification of matrix metalloproteinase 2
16. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors
17. High levels of messenger RNAs for tissue inhibitors of metalloproteinase (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastasis
18. TIMP-1 and adverse prognosis in non-small cell cancer
19. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma
20. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue in patients with renal cell carcinoma
21. Prognostic significance of morphologic parameters in renal cell carcinoma
22. TNM staging of renal cell carcinoma: Workgroup No. 3
23. Low-grade renal ell carcinoma. A clinicopathologic study of 53 cases
24. Decreased levels of CD44 protein and mRNA in prostate cancer. Correlation of tumor grade and ploidy
25. cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas
26. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system
27. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A
28. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay
29. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice
30. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2, and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis
31. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications
32. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma
33. Evaluation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma
34. Tumor cell invasion inhibited by TIMP-2
35. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor metalloproteinase1 gene in nude mice
36. Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease
37. Histopathologic findings in a highly invasive mouse mammary carcinoma transfected with human tissue inhibitor of metalloproteinases-1
38. TIMP-2 growth stimulatory activity: A concentration and cell-type specific response in the presence of insulin
39. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer
40. Role of tissue inhibitor of metalloproteinase-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells
41. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of pro-gelatinase A - A kinetic study
42. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2
43. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via c-AMP-dependent mechanism
44. Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2)
45. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1
46. Cell growth promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
47. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor
48. Matrix metalloproteinase inhibition: A review of anti-tumour activity